Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Amidinoureas for treating irritable bowel syndrome

Amidinoureas for treating irritable bowel syndrome

US Patent 4745131 · Granted May 17, 1988

Estimated economic value: $2,231,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

2-pyridinecarbothioamides, processes for preparation thereof1990
2-pyridinecarbothioamides and pharmaceutical compositions comprising the same us1989
Exogenously acidified antacid compositions having cytoprotective properties1989
Aryl substituted heterocycles for treating gastrointestinal motility dysfunction1987
Amidinoureas for treating irritable bowel syndrome1987
Amidinoureas for treating irritable bowel syndrome1987
Heterocyclic guanidines for treating gastrointestinal motility dysfunction1987
Amidinoureas for treating irritable bowel syndrome1986
Amidinoureas for treating irritable bowel syndrome1986
1,2,4-Triazines for treating gastrointestinal motility dysfunction1986
Quinoline and quinazoline derivatives for treating gastrointestinal motility dys1986
Guanidine derivatives for treating gastrointestinal motility dysfunction1986